Caroline Levy

Cannabis company Canopy Growth Corp (NYSE: CGC) — and by default its investment partner Constellation Brands, Inc. (NYSE: STZ) — are positioning themselves to be "all things to all people" in the cannabis market, according to Macquarie Research. Canopy is also positioning...

Coca-Cola Co (NYSE: KO)'s minority investment in sports drinks maker BodyArmor is a win-win scenario for both parties, according to Macquarie Research. The Analyst Analyst Caroline Levy maintained a Neutral rating on Coca-Cola with a 12-month price target of $50. (See Levy's track record...

After chatting with the British alcoholic beverage maker Diageo plc (NYSE: DEO)'s management, Macquarie Research maintained its bullish stance on the stock.  The Analyst Analyst  Caroline Levy maintains an Outperform on Diageo's London-listed stock with an unchanged 31-...

Constellation Brands Inc. (NYSE: STZ) invested $4 billion in the cannabis company Canopy Growth Corp (NYSE: CGC) in August for a 38-percent stake in the company — and that move earned the beverage company a sell-side downgrade Thursday.  The Analyst Macquarie Research analyst Caroline...

Macquarie's Caroline Levy provided clients with an outline of some of the key trends a panel of experts sees ahead for the alcohol market.  The sell-side firm recently hosted a panel of beer and cannabis experts including beer-guru Harry Schuhmacher, founder of Beer Business Daily;...

The beer industry is facing challenging times as production volume stagnates. U.S. beer sales volume was down 1 percent in 2017, according to statistics from the Brewers Association. Craft beer, which accounted for about 8 percent of overall dollar sales, saw sales volume rise by 5 percent....

Shares of Anheuser Busch Inbev (NYSE: BUD) fell Thursday following the company’s third-quarter earnings release and decision to cut its dividend in half to compensate for rising debt. The Analysts Bank of America analyst Paul Steegers reiterated an Underperform rating and a price...

Alcoholic beverage maker Constellation Brands, Inc. (NYSE: STZ) reported Thursday its second-quarter results, which sent the stock higher. Here's a summary of what some of the Street's top analysts are saying after the print. The Analysts Macquarie Research's Caroline Levy...

Beverage and snack maker PepsiCo, Inc. (NASDAQ: PEP) reported Tuesday its fiscal third-quarter results, which prompted Macquarie to downgrade the stock. The Analyst Caroline Levy downgraded PepsiCo from Outperform to Neutral with a price target lowered from $122 to $107. The Thesis PepsiCo showed...

Colgate-Palmolive Co. (NYSE: CL) reported weaker-than-expected second-quarter sales Friday and lowered its net sales growth projection. The Analysts Macquarie analyst Caroline Levy downgraded Colgate-Palmolive from Outperform to Neutral and lowered the price target from $74 to $65. The...

Household goods manufacturer Church & Dwight Co., Inc. (NYSE: CHD)'s first-quarter print showed 14.7-percent sales growth and 24-percent EPS growth, and the company raised its full-year sales outlook. The Analyst Macquarie analyst Caroline Levy upgraded Church & Dwight from Neutral...

Colgate-Palmolive Company (NYSE: CL) isn't necessarily the most exciting name for investors to talk about, but heading into 2018 the case can be made to be buyers of the stock. The Analyst Macquarie Research's Caroline Levy upgraded Colgate-Palmolive's stock from Neutral to...

CLSA’s Caroline Levy reported that the fourth cosmetics survey of Chinese women revealed that the purchase rate of Estee Lauder Companies Inc’s (NYSE: EL) brands remained flat or improved, while desirability and intent-to-switch rates had declined from the very high levels seen in...

U.S. retail sales, released by IRI, for the four weeks ended August 7 showed Constellation Brands, Inc. (NYSE: STZ)'s beer sales grew 16 percent. Monster Beverage Corporation (NASDAQ: MNST)'s sales rose 3.4 percent and PepsiCo, Inc. (NYSE: PEP)'s overall retail sales were flat. Constellation Brands...

CLSA reiterated its Outperform rating on Anheuser Busch Inbev SA (ADR) (NYSE: BUD) and retained the 12-month price objective of $145.00. Analysts, led by Caroline Levy, see an imminent inflection point, indicating the shift in rapidly-growing high-end brands. They are confident that the move would...